FEDOROVÁ, Veronika, Veronika POSPÍŠILOVÁ, Tereza VÁŇOVÁ, Kateřina AMRUZ ČERNÁ, Pavel ABAFFY, Jiří SEDMÍK, Jan RAŠKA, Simona VOCHYÁNOVÁ, Zuzana MATŮŠOVÁ, Jana HOUSEROVÁ, Lukáš VALIHRACH, Zdeněk HODNÝ and Dáša BOHAČIAKOVÁ. Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration. MOLECULAR ONCOLOGY. ENGLAND: WILEY, 2023, vol. 17, No 4, p. 647-663. ISSN 1574-7891. Available from: https://dx.doi.org/10.1002/1878-0261.13389.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration
Authors FEDOROVÁ, Veronika (203 Czech Republic, belonging to the institution), Veronika POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), Tereza VÁŇOVÁ (203 Czech Republic, belonging to the institution), Kateřina AMRUZ ČERNÁ (203 Czech Republic, belonging to the institution), Pavel ABAFFY (703 Slovakia), Jiří SEDMÍK (203 Czech Republic, belonging to the institution), Jan RAŠKA (203 Czech Republic, belonging to the institution), Simona VOCHYÁNOVÁ (203 Czech Republic, belonging to the institution), Zuzana MATŮŠOVÁ (203 Czech Republic), Jana HOUSEROVÁ (203 Czech Republic), Lukáš VALIHRACH (203 Czech Republic), Zdeněk HODNÝ (203 Czech Republic) and Dáša BOHAČIAKOVÁ (703 Slovakia, guarantor, belonging to the institution).
Edition MOLECULAR ONCOLOGY, ENGLAND, WILEY, 2023, 1574-7891.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.600 in 2022
RIV identification code RIV/00216224:14110/23:00130401
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/1878-0261.13389
UT WoS 000934781400001
Keywords in English cerebral organoids; GLICO; glioblastoma; induced pluripotent stem cells
Tags 14110517, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 08:16.
Abstract
It is currently challenging to adequately model the growth and migration of glioblastoma using two-dimensional (2D) in vitro culture systems as they quickly lose the original, patient-specific identity and heterogeneity. However, with the advent of three-dimensional (3D) cell cultures and human-induced pluripotent stem cell (iPSC)-derived cerebral organoids (COs), studies demonstrate that the glioblastoma-CO (GLICO) coculture model helps to preserve the phenotype of the patient-specific tissue. Here, we aimed to set up such a model using mature COs and develop a pipeline for subsequent analysis of cocultured glioblastoma. Our data demonstrate that the growth and migration of the glioblastoma cell line within the mature COs are significantly increased in the presence of extracellular matrix proteins, shortening the time needed for glioblastoma to initiate migration. We also describe in detail the method for the visualization and quantification of these migrating cells within the GLICO model. Lastly, we show that this coculture model (and the human brain-like microenvironment) can significantly transform the gene expression profile of the established U87 glioblastoma cell line into proneural and classical glioblastoma cell types.
Links
EF16_013/0001761, research and development projectName: RECETOX RI
EF17_043/0009632, research and development projectName: CETOCOEN Excellence
EF19_073/0016943, research and development projectName: Interní grantová agentura Masarykovy univerzity
GA20-15728S, research and development projectName: Nové přístupy k překonání terapeutické rezistence u glioblastoma multiforme se zaměřením na buněčnou senescenci a model mozkového organoidu
Investor: Czech Science Foundation
GA21-21510S, research and development projectName: Studium molekulárních mechanismů vzniku Alzheimerovy choroby pomocí cerebrálních organoidů (Acronym: AD Brain Organoids)
Investor: Czech Science Foundation
GJ18-25429Y, research and development projectName: Funkční studie mikroRNA u nerálních kmenových buněk v průběhu diferenciace
Investor: Czech Science Foundation
LM2018121, research and development projectName: Výzkumná infrastruktura RECETOX (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, RECETOX RI
LM2018129, research and development projectName: Národní infrastruktura pro biologické a medicínské zobrazování Czech-BioImaging
Investor: Ministry of Education, Youth and Sports of the CR
LM2018132, research and development projectName: Národní centrum lékařské genomiky (Acronym: NCLG)
Investor: Ministry of Education, Youth and Sports of the CR, National Center for Medical Genomics
MUNI/A/1398/2021, interní kód MUName: Zdroje pro tkáňové inženýrství 12 (Acronym: TissueEng 12)
Investor: Masaryk University
MUNI/IGA/1273/2021, interní kód MUName: Investigation of the role of candidate miRNAs in neural stem cells’ identity
Investor: Masaryk University
MUNI/R/1321/2021, interní kód MUName: Career Restart - Next generation sequencing in neural development and disease
Investor: Masaryk University, CAREER RESTART
MUNI/R/1697/2020, interní kód MUName: Career Restart - Stem Cell-Based Models of Neurodegeneration
Investor: Masaryk University, CAREER RESTART
MUNI/11/SUP/01/2022, interní kód MUName: Role miRNA v šíření Glioblastoma multiforme mozkovou tkání in vitro
Investor: Masaryk University, Start-up
MUNI/11/SUP/19/2020, interní kód MUName: Efekt buněčného stárnutí na vznik Alzheimerovy nemoci
Investor: Masaryk University
NU21-08-00373, research and development projectName: Patogeny indukovaná senescence jako spouštěcí faktor Alzheimerovy nemoci (Acronym: Patogeny u AD)
Investor: Ministry of Health of the CR, Subprogram 1 - standard
NV19-08-00472, research and development projectName: Klinicky relevantní biochemické, imunologické a buněčné biomarkery Alzheimerovy nemoci a stárnutí (Acronym: BioMAD)
Investor: Ministry of Health of the CR
ROZV/23/LF19/2019, interní kód MUName: Využití in vitro kultivovaných cerebrálních organoidů pro modelování patogeneze Alzheimerovy choroby
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
ROZV/28/LF22/2020, interní kód MUName: ln vitro modelováni Alzheimerovy choroby pomoci nově derivovaných indukovaných plunpotentnich kmenových buněk z pacientu se spontánní formou onemocnění.
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
PrintDisplayed: 21/7/2024 17:23